brickell
biotech
report
third
quarter
financial
results
provide
corporate
update
november
boulder
globe
newswire
brickell
biotech
brickell
nasdaq
bbi
pharmaceutical
company
focused
developing
innovative
differentiated
prescription
therapeutics
treatment
debilitating
skin
diseases
today
announced
report
financial
results
third
quarter
ended
september
market
close
thursday
november
brickell
management
host
conference
call
webcast
pm
et
thursday
november
discuss
financial
results
recent
corporate
highlights
access
call
please
dial
outside
provide
conference
id
number
access
live
webcast
please
go
investors
section
brickell
website
https
following
live
webcast
archived
version
call
available
website
brickell
brickell
biotech
pharmaceutical
company
focused
developing
innovative
differentiated
prescription
therapeutics
treatment
debilitating
skin
diseases
brickell
pipeline
consists
potential
novel
therapeutics
hyperhidrosis
prevalent
dermatological
conditions
brickell
executive
management
team
board
directors
bring
extensive
experience
product
development
global
commercialization
served
leadership
roles
large
global
pharmaceutical
companies
biotechs
developed
launched
successful
products
including
several
achieved
iconic
status
brickell
strategy
leverage
experience
acquire
develop
commercialize
innovative
products
brickell
believes
successful
currently
underserved
dermatology
global
marketplace
information
visit
https
